FDA Label for Dermabon Multi Symptom Psoriasis Control

View Indications, Usage & Precautions

Dermabon Multi Symptom Psoriasis Control Product Label

The following document was submitted to the FDA by the labeler of this product Dermabon De Chihuahua, S.a. De C.v.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Drug Facts




Active Ingredients



Coal Tar / 2.13%


Purposes



Anti-Psoriasis / Anti-Dandruff


Uses



For the relief of psoriasis and dandruff


Warnings



  • For external use only.
  • Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.
  • If condition worsens or does not improve after regular use of this product as directed, consult a doctor.
  • Use caution when exposing skin to sunlight after applying this product, it may increase your tendency to sunburn up to 24 hours after application.

Do Not Use



  • for prolonged periods without consulting a doctor.
  • do not use this proudct with other forms of psoriasis therapy, such as ultraviolet radiation or prescription drugs, unless directed to do so by a doctor.
  • If condition covers a large area of the body, consult your doctor before using this product. 

Directions



Apply in affected areas, let it rest, and rinse.


Inactive Ingredients



Borax, Ethyl Alcohol, Glycerin, Glyceryl Stearate, Lanolin, Methylparaben, Sodium Hypoochlorite, Stearic Acid, Petrolatum Oil, Vitamin E, Soap base and Water.


Package Labeling:




* Please review the disclaimer below.